Optimal Use of BRAF Targeting Therapy in the Immunotherapy Era
Crossref DOI link: https://doi.org/10.1007/s11912-016-0554-5
Published Online: 2016-09-09
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wood, Kevin
Luke, Jason J.
License valid from 2016-09-09
